A 37-year-old male HIV-1 patient is receiving the Biktarvy treatment. He has experienced severe tachycardia; after checking the medical history of patients and performing a drug blood-concentration test, doctors are able to know that he has been taken an antiarrhythmic medication a half hour prior to giving Biktarvy.
Questions
- What is the name of the drug (antiarrhythmic) that is contraindicated to Biktarvy?
- What is the class of that antiarrhythmic drug?
- Which particular transport protein channel is inhibited by Biktarvy through which antiarrhythmic drugs are being processed?
MBH/PS